Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 10

1.

Integrating disease progression models, non-clinical pharmacokinetic data and treatment response endpoints to optimize intravitreal dosing regimens.

Basile AS, Johnson TR, Klamerus KJ, Zhou D, Sultan MB, Amantea M, Nickens DJ.

Int J Clin Pharmacol Ther. 2014 Jul;52(7):574-86. doi: 10.5414/CP201998.

PMID:
24755127
[PubMed - in process]
2.

A retrospective, pooled data analysis of the safety of pegaptanib sodium in the treatment of age-related macular degeneration in subjects with or without diabetes mellitus.

Dombi T, Kwok KK, Sultan MB.

BMC Ophthalmol. 2012 Aug 8;12:37. doi: 10.1186/1471-2415-12-37.

PMID:
22871086
[PubMed - indexed for MEDLINE]
Free PMC Article
3.

Epidemiology, risk factors and management of paediatric diabetic retinopathy.

Sultan MB, Starita C, Huang K.

Br J Ophthalmol. 2012 Mar;96(3):312-7. doi: 10.1136/bjophthalmol-2011-300169. Epub 2012 Jan 12. Review.

PMID:
22241926
[PubMed - indexed for MEDLINE]
4.

Changes in vision- and health-related quality of life in patients with diabetic macular edema treated with pegaptanib sodium or sham.

Loftus JV, Sultan MB, Pleil AM; Macugen 1013 Study Group.

Invest Ophthalmol Vis Sci. 2011 Sep 29;52(10):7498-505. doi: 10.1167/iovs.11-7613.

PMID:
21896838
[PubMed - indexed for MEDLINE]
Free Article
5.

A phase 2/3, multicenter, randomized, double-masked, 2-year trial of pegaptanib sodium for the treatment of diabetic macular edema.

Sultan MB, Zhou D, Loftus J, Dombi T, Ice KS; Macugen 1013 Study Group.

Ophthalmology. 2011 Jun;118(6):1107-18. doi: 10.1016/j.ophtha.2011.02.045. Epub 2011 May 6.

PMID:
21529957
[PubMed - indexed for MEDLINE]
6.

The role of benzalkonium chloride in the occurrence of punctate keratitis: a meta-analysis of randomized, controlled clinical trials.

Trocme S, Hwang LJ, Bean GW, Sultan MB.

Ann Pharmacother. 2010 Dec;44(12):1914-21. doi: 10.1345/aph.1P268. Epub 2010 Nov 30.

PMID:
21119099
[PubMed - indexed for MEDLINE]
7.

Assessing the Importance of IOP Variables in Glaucoma Using a Modified Delphi Process.

Lee PP, Sultan MB, Grunden JW, Cioffi GA; IOP Consensus Panel.

J Glaucoma. 2010 Jun-Jul;19(5):281-7. doi: 10.1097/IJG.0b013e3181b4ca8d.

PMID:
19855301
[PubMed - indexed for MEDLINE]
8.

Understanding the importance of IOP variables in glaucoma: a systematic review.

Sultan MB, Mansberger SL, Lee PP.

Surv Ophthalmol. 2009 Nov-Dec;54(6):643-62. doi: 10.1016/j.survophthal.2009.05.001. Epub 2009 Aug 8. Review.

PMID:
19665744
[PubMed - indexed for MEDLINE]
9.

Assessing the efficacy of latanoprost vs timolol using an alternate efficacy parameter: the intervisit intraocular pressure range.

Varma R, Hwang LJ, Grunden JW, Bean GW, Sultan MB.

Am J Ophthalmol. 2009 Aug;148(2):221-6. doi: 10.1016/j.ajo.2009.02.035. Epub 2009 May 9.

PMID:
19427617
[PubMed - indexed for MEDLINE]
10.

The failure of amalgam dental restorations due to cyclic fatigue crack growth.

Arola D, Huang MP, Sultan MB.

J Mater Sci Mater Med. 1999 Jun;10(6):319-27.

PMID:
15348132
[PubMed]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk